Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL: 5,775 Adverse Event Reports & Safety Profile

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy
5,775
Total FAERS Reports
95 (1.6%)
Deaths Reported
3,369
Hospitalizations
5,775
As Primary/Secondary Suspect
83
Life-Threatening
57
Disabilities

First Report: 1996 · Latest Report: 20250317

What Are the Most Common HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL Side Effects?

#1 Most Reported
Sprue-like enteropathy
2,453 reports (42.5%)
#2 Most Reported
Gastrooesophageal reflux disease
1,317 reports (22.8%)
#3 Most Reported
Acute kidney injury
1,051 reports (18.2%)

All HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Sprue-like enteropathy 2,453 42.5% 33 1,819
Gastrooesophageal reflux disease 1,317 22.8% 12 944
Acute kidney injury 1,051 18.2% 29 917
Haemorrhoids 965 16.7% 5 709
Weight decreased 688 11.9% 7 471
Hiatus hernia 664 11.5% 8 516
Large intestine polyp 601 10.4% 4 428
Diverticulitis 583 10.1% 4 437
Diverticulum 583 10.1% 3 452
Constipation 582 10.1% 7 397
Diarrhoea 564 9.8% 5 333
Dizziness 481 8.3% 3 291
Diverticulum intestinal 479 8.3% 7 345
Irritable bowel syndrome 462 8.0% 1 333
Hypotension 392 6.8% 9 318
Malabsorption 359 6.2% 7 153
Syncope 324 5.6% 8 250
Coeliac disease 300 5.2% 5 257
Chronic kidney disease 262 4.5% 8 178
Nausea 245 4.2% 3 130

Who Reports HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL Side Effects? Age & Gender Data

Gender: 62.3% female, 37.7% male. Average age: 66.6 years. Most reports from: US. View detailed demographics →

Is HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL Getting Safer? Reports by Year

YearReportsDeathsHosp.
2001 2 1 1
2002 25 1 16
2003 68 1 48
2004 123 1 89
2005 213 3 151
2006 230 1 158
2007 311 2 214
2008 326 5 228
2009 371 5 263
2010 369 7 251
2011 371 4 260
2012 350 8 235
2013 377 3 240
2014 432 13 236
2015 371 9 199
2016 229 6 145
2017 150 1 74
2018 187 0 95
2019 140 1 54
2020 57 0 18
2021 65 0 31
2022 56 0 38
2023 72 1 47
2024 28 0 18
2025 12 0 8

View full timeline →

What Is HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL Used For?

IndicationReports
Hypertension 3,244
Product used for unknown indication 2,119
Essential hypertension 130
Blood pressure measurement 55
Blood pressure management 47
Blood pressure abnormal 38
Blood pressure increased 24
Drug abuse 13
Dyslipidaemia 8
Atrial fibrillation 7

HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL vs Alternatives: Which Is Safer?

HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL vs HYDROCHLOROTHIAZIDE\QUINAPRIL HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL vs HYDROCHLOROTHIAZIDE\RAMIPRIL HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL vs HYDROCHLOROTHIAZIDE\SPIRONOLACTONE HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL vs HYDROCHLOROTHIAZIDE\TELMISARTAN HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL vs HYDROCHLOROTHIAZIDE\TRIAMTERENE HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL vs HYDROCHLOROTHIAZIDE\VALSARTAN HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL vs HYDROCODONE HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL vs HYDROCODONE/ACETAMINOPHEN HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL vs HYDROCODONE\IBUPROFEN HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL vs HYDROCODONE+PARACETAMOL

Official FDA Label for HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL

Official prescribing information from the FDA-approved drug label.